Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling
Nature immunology, 2008•nature.com
The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative
nuclear factor-κB (NF-κB) signaling in resting cells by targeting NF-κB–inducing kinase (NIK)
for ubiquitin-dependent degradation, thus preventing processing of the NF-κB2 precursor
protein p100 to release p52. However, the respective functions of TRAF2 and TRAF3 in NIK
degradation and activation of alternative NF-κB signaling have remained elusive. We now
show that CD40 or BAFF receptor activation result in TRAF3 degradation in a cIAP1-cIAP2 …
nuclear factor-κB (NF-κB) signaling in resting cells by targeting NF-κB–inducing kinase (NIK)
for ubiquitin-dependent degradation, thus preventing processing of the NF-κB2 precursor
protein p100 to release p52. However, the respective functions of TRAF2 and TRAF3 in NIK
degradation and activation of alternative NF-κB signaling have remained elusive. We now
show that CD40 or BAFF receptor activation result in TRAF3 degradation in a cIAP1-cIAP2 …
Abstract
The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-κB (NF-κB) signaling in resting cells by targeting NF-κB–inducing kinase (NIK) for ubiquitin-dependent degradation, thus preventing processing of the NF-κB2 precursor protein p100 to release p52. However, the respective functions of TRAF2 and TRAF3 in NIK degradation and activation of alternative NF-κB signaling have remained elusive. We now show that CD40 or BAFF receptor activation result in TRAF3 degradation in a cIAP1-cIAP2- and TRAF2-dependent way owing to enhanced cIAP1, cIAP2 TRAF3-directed ubiquitin ligase activity. Receptor-induced activation of cIAP1 and cIAP2 correlated with their K63-linked ubiquitination by TRAF2. Degradation of TRAF3 prevented association of NIK with the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, which resulted in NIK stabilization and NF-κB2-p100 processing. Constitutive activation of this pathway causes perinatal lethality and lymphoid defects.
nature.com
